Altimmune, Inc. (ALT) Tops Q3 EPS by 4c
Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.